Clinical Value the Neutrophil CD64 Index in Predicting the Severity of Hemorrhagic Fever With Renal Syndrome

Key Points

• To evaluate the neutrophil CD64 index as a biomarker for severity prediction in hemorrhagic fever with renal syndrome (HFRS).
• Analyzed neutrophil CD64 levels in patients with HFRS
• Monitored disease progression over time
• Assessed treatment efficacy using biomarker levels
• Higher neutrophil CD64 index correlates with increased disease severity
• The index can effectively monitor disease progression
• Potential to guide treatment decisions based on biomarker changes